Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Akzo Nobel N.V. logo
AKZA.AS
Akzo Nobel N.V.
13:11:05
59.18
0.0000 (%0.00)
Previous Close: 59.62
Day Low58.86
Day High59.88
Bid
Ask

AKZA.AS: Akzo Nobel N.V. Financials

Akzo Nobel N.V. Income Statement

Total revenue
Net income
Gross margin TTM
39.86%
Operating margin TTM
7.62%
Net profit margin TTM
6.25%
Return on investment TTM
13.63%
Period end31/12/202531/12/202431/12/202331/12/2022
Total revenue10,158,000,00010,711,000,00010,668,000,00010,846,000,000
Operating income774,000,000917,000,0001,029,000,000708,000,000
Net income635,000,000542,000,000442,000,000352,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Total revenue10,158,000,00010,711,000,00010,668,000,00010,846,000,000
Cost of revenue6,109,000,0006,374,000,0006,434,000,0006,923,000,000
Gross profit4,049,000,0004,337,000,0004,234,000,0003,923,000,000
Research and development expenses0296,000,000270,000,000258,000,000
General and administrative expenses3,275,000,000323,000,000328,000,000338,000,000
Selling and marketing expenses01,240,000,0001,210,000,0001,193,000,000
Selling, general and administrative expenses3,275,000,0001,563,000,0001,538,000,0001,531,000,000
Other expenses01,561,000,0001,397,000,0001,426,000,000
Operating expenses3,275,000,0003,420,000,0003,205,000,0003,215,000,000
Cost and expenses9,384,000,0009,794,000,0009,639,000,00010,138,000,000
Net interest income-199,000,000-102,000,000-123,000,000-77,000,000
Interest income088,000,00069,000,00029,000,000
Interest expense199,000,000190,000,000192,000,000106,000,000
Depreciation and amortization378,000,000371,000,000355,000,000362,000,000
EBITDA1,542,000,0001,399,000,0001,413,000,0001,052,000,000
EBIT1,164,000,0001,028,000,0001,056,000,000690,000,000
Non-operating income (excl. interest)-390,000,000-111,000,000-27,000,00018,000,000
Operating income774,000,000917,000,0001,029,000,000708,000,000
Total other income/expenses (net)224,000,000-79,000,000-245,000,000-106,000,000
Income before tax998,000,000838,000,000784,000,000602,000,000
Income tax expense326,000,000246,000,000296,000,000214,000,000
Net income from continuing operations672,000,000592,000,000488,000,000388,000,000
Net income from discontinued operations-1,000,0000-5,000,000-10,000,000
Other adjustments to net income0000
Net income635,000,000542,000,000442,000,000352,000,000
Net income deductions0000
Bottom line net income635,000,000542,000,000442,000,000352,000,000
EPS4332
Diluted EPS4332
Weighted average shares outstanding171,000,000170,728,870170,600,000174,735,139
Weighted average diluted shares outstanding172,086,721171,518,987171,338,756175,313,498

Akzo Nobel N.V. Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
Current ratio MRQ
Long-term debt / assets MRQ
3,476,000,000%
Total debt / assets MRQ
Period end31/12/202531/12/202431/12/202331/12/2022
Total assets13,952,000,00014,249,000,00014,558,000,00014,741,000,000
Total liabilities9,130,000,0009,433,000,00010,012,000,00010,193,000,000
Total equity4,659,000,0004,574,000,0004,322,000,0004,333,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Cash and cash equivalents1,618,000,0001,302,000,0001,513,000,0001,450,000,000
Short-term investments302,000,000165,000,000265,000,000336,000,000
Cash and short-term investments1,920,000,0001,467,000,0001,778,000,0001,786,000,000
Net receivables2,612,000,0002,273,000,0002,276,000,0002,215,000,000
Accounts receivable2,403,000,0002,144,000,0002,187,000,0002,123,000,000
Other receivables209,000,000129,000,00089,000,00092,000,000
Inventory1,529,000,0001,721,000,0001,649,000,0001,843,000,000
Prepaid expenses35,000,00042,000,00039,000,00058,000,000
Other current assets-35,000,000333,000,000302,000,000342,000,000
Total current assets6,061,000,0005,836,000,0006,044,000,0006,244,000,000
Property, plant and equipment (net)2,333,000,0002,440,000,0002,296,000,0002,259,000,000
Goodwill1,392,000,0001,443,000,0001,430,000,0001,377,000,000
Intangible assets2,406,000,0002,606,000,0002,651,000,0002,695,000,000
Goodwill and intangible assets3,798,000,0004,049,000,0004,081,000,0004,072,000,000
Long-term investments468,000,000250,000,00044,000,000-59,000,000
Tax assets792,000,000422,000,000512,000,000498,000,000
Other non-current assets500,000,0001,252,000,0001,581,000,0001,727,000,000
Total non-current assets7,891,000,0008,413,000,0008,514,000,0008,497,000,000
Other assets0000
Total assets13,952,000,00014,249,000,00014,558,000,00014,741,000,000
Total payables2,829,000,0002,844,000,0002,523,000,0002,442,000,000
Accounts payable2,690,000,0002,740,000,0002,312,000,0002,206,000,000
Other payables139,000,000104,000,000211,000,000236,000,000
Accrued expenses00598,000,000516,000,000
Short-term debt1,112,000,0001,606,000,0002,309,000,0002,457,000,000
Capital lease obligations (current)80,000,00091,000,00089,000,00086,000,000
Tax payables0120,000,000211,000,000420,000,000
Deferred revenue0010,000,0000
Other current liabilities186,000,000189,000,000177,000,000245,000,000
Total current liabilities4,207,000,0004,730,000,0005,706,000,0005,746,000,000
Long-term debt3,476,000,0003,470,000,0002,971,000,0003,134,000,000
Capital lease obligations (non-current)194,000,000201,000,000194,000,000198,000,000
Deferred revenue (non-current)00194,000,0000
Deferred tax liabilities (non-current)487,000,000491,000,000557,000,000561,000,000
Other non-current liabilities766,000,000541,000,000390,000,000554,000,000
Total non-current liabilities4,923,000,0004,703,000,0004,306,000,0004,447,000,000
Other liabilities0000
Capital lease obligations274,000,000292,000,000283,000,000284,000,000
Total liabilities9,130,000,0009,433,000,00010,012,000,00010,193,000,000
Treasury stock0000
Preferred stock0000
Common stock86,000,00085,000,00085,000,00087,000,000
Retained earnings5,374,000,0005,068,000,000679,000,0004,936,000,000
Additional paid-in capital0000
Accumulated other comprehensive income/loss-801,000,000-579,000,000-711,000,000-690,000,000
Other stockholders' equity004,269,000,0000
Total stockholders' equity4,659,000,0004,574,000,0004,322,000,0004,333,000,000
Total equity4,822,000,0004,816,000,0004,546,000,0004,548,000,000
Minority interest163,000,000242,000,000224,000,000215,000,000
Total liabilities and total equity13,952,000,00014,249,000,00014,558,000,00014,741,000,000
Total investments770,000,000415,000,000309,000,000277,000,000
Total debt4,862,000,0005,368,000,0005,563,000,0005,875,000,000
Net debt3,244,000,0004,066,000,0004,050,000,0004,425,000,000

Akzo Nobel N.V. Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
Revenue / share TTM
Operating cash flow TTM
Period end31/12/202531/12/202431/12/202331/12/2022
Cash from operations915,000,000668,000,0001,120,000,000254,000,000
Cash from investing424,000,000-132,000,000-144,000,000-1,095,000,000
Cash from financing-964,000,000-684,000,000-827,000,0001,141,000,000
Net change in cash316,000,000-180,000,00055,000,000286,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Net income636,000,000542,000,000442,000,000388,000,000
Depreciation and amortization378,000,000371,000,000355,000,000368,000,000
Deferred income tax00-9,000,000-8,000,000
Stock-based compensation00016,000,000
Change in working capital472,000,000-199,000,000-33,000,000-573,000,000
Accounts receivable012,000,000-111,000,000-95,000,000
Inventory0-83,000,000131,000,000-134,000,000
Accounts payable0-135,000,000234,000,000-280,000,000
Other working capital472,000,0007,000,000-287,000,000-64,000,000
Other non-cash items-571,000,000-46,000,000365,000,00063,000,000
Net cash from operating activities915,000,000668,000,0001,120,000,000254,000,000
Investments in property, plant and equipment-309,000,000-306,000,000-286,000,000-292,000,000
Acquisitions (net)799,000,0002,000,000-18,000,000-552,000,000
Purchases of investments-314,000,000-320,000,000-64,000,000-1,361,000,000
Sales/maturities of investments174,000,000423,000,000142,000,0001,084,000,000
Other investing activities74,000,00069,000,00082,000,00026,000,000
Net cash from investing activities424,000,000-132,000,000-144,000,000-1,095,000,000
Net debt issuance-582,000,000-295,000,000-459,000,0002,189,000,000
Long-term net debt issuance-582,000,000-295,000,000-459,000,0002,189,000,000
Short-term net debt issuance0000
Net stock issuance000-669,000,000
Net common stock issuance000-669,000,000
Common stock issuance0000
Common stock repurchased000-669,000,000
Net preferred stock issuance0000
Net dividends paid-339,000,000-385,000,000-343,000,000-350,000,000
Common dividends paid-339,000,000-385,000,000-343,000,000-350,000,000
Preferred dividends paid0000
Other financing activities-43,000,000-4,000,000-25,000,000-29,000,000
Net cash from financing activities-964,000,000-684,000,000-827,000,0001,141,000,000
Effect of FX changes on cash-59,000,000-32,000,000-94,000,000-14,000,000
Net change in cash316,000,000-180,000,00055,000,000286,000,000
Cash at end of period1,618,000,0001,273,000,0001,453,000,0001,398,000,000
Cash at beginning of period1,302,000,0001,453,000,0001,398,000,0001,112,000,000
Operating cash flow915,000,000741,000,0001,210,000,000291,000,000
Capital expenditure-309,000,000-306,000,000-286,000,000-292,000,000
Free cash flow606,000,000362,000,000834,000,000-29,000,000
Income taxes paid0000
Interest paid0000